Last 12 months
Inside the activity.
2 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2025 Filed Sep 11, 2025 22:03 UTC |
Gagnon Robert E.Chief Financial Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-003320 · form4.xml · nonDerivative · entry 1 Gagnon Robert E. · CIK 0001504983 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · shares: Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service. Read SEC document |
| September 02, 2025 Filed Sep 11, 2025 22:03 UTC |
Gagnon Robert E.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0000905148-25-003320 · form4.xml · derivative · entry 2 Gagnon Robert E. · CIK 0001504983 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-09-01 F2 · derivative.exercise_date: The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:15 UTC |
Gallagher CamDirector
|
GrantCommon Stock | 869,565 | $1.15 | $999,999.75 |
DisclosureSEC source: 0000905148-25-003152 · form4.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,810,430 Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:13 UTC |
Ainsworth SeanDirector
|
GrantCommon Stock | 86,956 | $1.15 | $99,999.40 |
DisclosureSEC source: 0000905148-25-003151 · form4.xml · nonDerivative · entry 1 Ainsworth Sean · CIK 0001830296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,818 Read SEC document |
| May 05, 2025 Filed May 6, 2025 22:05 UTC |
Foundation Fighting Blindness Retinal Degeneration FundDirector · 10% owner · See Remarks
Foundation Fighting Blindness, Inc.Director · 10% owner · See Remarks
|
ConversionSeries A Non-Voting Convertible Preferred Stock · Derivative | 6,927.419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001578563-25-000238 · primary_doc.xml · derivative · entry 2 Foundation Fighting Blindness Retinal Degeneration Fund · CIK 0002042266 · Director · 10% owner · See Remarks Foundation Fighting Blindness, Inc. · CIK 0002042532 · Director · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,927,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025. F3 · price: The shares of Preferred Stock were issued to the Reporting Persons in connection with a merger and reorganization in a stock-for-stock transaction. F1 · derivative.expiration_date: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025. F2 · ownership.direct: Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold. Read SEC document |
| May 05, 2025 Filed May 6, 2025 22:05 UTC |
Foundation Fighting Blindness Retinal Degeneration FundDirector · 10% owner · See Remarks
Foundation Fighting Blindness, Inc.Director · 10% owner · See Remarks
|
ConversionCommon Stock | 6,927,419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001578563-25-000238 · primary_doc.xml · nonDerivative · entry 1 Foundation Fighting Blindness Retinal Degeneration Fund · CIK 0002042266 · Director · 10% owner · See Remarks Foundation Fighting Blindness, Inc. · CIK 0002042532 · Director · 10% owner · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,492,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A non-voting convertible preferred stock (the "Preferred Stock") automatically converted into 1,000 shares of the Issuer's common stock as of 5:00 p.m. Eastern time on the third business day after the date that the Issuer's stockholders approved the conversion of the Preferred Stock into shares of the Issuer's common stock, which approval occurred on April 30, 2025. F2 · ownership.direct: Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:03 UTC |
Bennett JeanDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001425 · form4.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:03 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001425 · form4.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,525 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 17:08 UTC |
MANUSO JAMES S JDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001429 · form4.xml · derivative · entry 2 MANUSO JAMES S J · CIK 0001236365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 17:08 UTC |
MANUSO JAMES S JDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001429 · form4.xml · nonDerivative · entry 1 MANUSO JAMES S J · CIK 0001236365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,763 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:06 UTC |
Graves Adrienne LDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001428 · form4.xml · derivative · entry 2 Graves Adrienne L · CIK 0001326192 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:06 UTC |
Graves Adrienne LDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001428 · form4.xml · nonDerivative · entry 1 Graves Adrienne L · CIK 0001326192 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,504 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:09 UTC |
Rodgers Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001430 · form4.xml · derivative · entry 2 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:09 UTC |
Rodgers Richard JDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001430 · form4.xml · nonDerivative · entry 1 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,655 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:05 UTC |
Gallagher CamDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001427 · form4.xml · derivative · entry 2 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:05 UTC |
Gallagher CamDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001427 · form4.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 940,865 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:02 UTC |
Ainsworth SeanDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001424 · form4.xml · derivative · entry 2 Ainsworth Sean · CIK 0001830296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:02 UTC |
Ainsworth SeanDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001424 · form4.xml · nonDerivative · entry 1 Ainsworth Sean · CIK 0001830296 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,862 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:04 UTC |
Benton SusanDirector
|
GrantStock Option (Right to Buy) · Derivative | 79,592 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0000905148-25-001426 · form4.xml · derivative · entry 2 Benton Susan · CIK 0001373649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,592 Underlying: Common Stock · 79,592 shares Expires 2035-04-29 F2 · derivative.exercise_date: The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:04 UTC |
Benton SusanDirector
|
GrantCommon Stock | 79,504 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-001426 · form4.xml · nonDerivative · entry 1 Benton Susan · CIK 0001373649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,527 F1 · shares: Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:10 UTC |
Magrath GeorgeDirector · Chief Executive Officer
|
GrantWarrants (right to buy) · Derivative | 392,157 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0000905148-25-001007 · form4.xml · derivative · entry 2 Magrath George · CIK 0001999390 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,157 Underlying: Common Stock · 392,157 shares Expires 2030-03-24 F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F2 · derivative.exercise_date: These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:10 UTC |
Magrath GeorgeDirector · Chief Executive Officer
|
GrantCommon Stock | 392,157 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-001007 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,322,004 F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:08 UTC |
Gallagher CamDirector
|
GrantWarrants (right to buy) · Derivative | 784,314 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0000905148-25-001006 · form4.xml · derivative · entry 2 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 784,314 Underlying: Common Stock · 784,314 shares Expires 2030-03-24 F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F2 · derivative.exercise_date: These warrants are immediately exercisable and may be called by the Issuer at any time starting with 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's common stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:08 UTC |
Gallagher CamDirector
|
GrantCommon Stock | 784,314 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-001006 · form4.xml · nonDerivative · entry 1 Gallagher Cam · CIK 0001557832 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 861,361 F1 · kind: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. F1 · price: Each share of common stock was purchased together with a warrant to purchase one share of common stock in a transaction that is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d) thereunder. The combined purchase price of each pair of common stock and warrant was $1.275. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:56 UTC |
SCHACHLE JOSEPH KChief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,500 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000942 · form4.xml · derivative · entry 2 SCHACHLE JOSEPH K · CIK 0001145914 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:56 UTC |
SCHACHLE JOSEPH KChief Operating Officer
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000942 · form4.xml · nonDerivative · entry 1 SCHACHLE JOSEPH K · CIK 0001145914 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,500 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:52 UTC |
Jhaveri Nirav S.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,500 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000939 · form4.xml · derivative · entry 2 Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:52 UTC |
Jhaveri Nirav S.Chief Financial Officer
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000939 · form4.xml · nonDerivative · entry 1 Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,293 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:50 UTC |
Jayagopal AshwathChief Scientific & Dev. Ofc.
|
GrantEmployee Stock Option (right to buy) · Derivative | 52,500 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000938 · form4.xml · derivative · entry 2 Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:50 UTC |
Jayagopal AshwathChief Scientific & Dev. Ofc.
|
GrantCommon Stock | 52,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000938 · form4.xml · nonDerivative · entry 1 Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,807 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:53 UTC |
Magrath GeorgeChief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 330,697 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000940 · form4.xml · derivative · entry 2 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,697 Underlying: Common Stock · 330,697 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:53 UTC |
Magrath GeorgeChief Executive Officer
|
GrantCommon Stock | 330,697 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000940 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 929,847 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:49 UTC |
Hoffmann BernhardSVP of Corp. Dev.
|
GrantEmployee Stock Option (right to buy) · Derivative | 29,500 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000937 · form4.xml · derivative · entry 2 Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,500 Underlying: Common Stock · 29,500 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:49 UTC |
Hoffmann BernhardSVP of Corp. Dev.
|
GrantCommon Stock | 29,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000937 · form4.xml · nonDerivative · entry 1 Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,446 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:54 UTC |
Zaremba Rabourn AmySVP of Finance
|
GrantEmployee Stock Option (right to buy) · Derivative | 39,500 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000905148-25-000941 · form4.xml · derivative · entry 2 Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,500 Underlying: Common Stock · 39,500 shares Expires 2035-03-12 F2 · derivative.exercise_date: The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service. Read SEC document |
| March 13, 2025 Filed Mar 18, 2025 00:54 UTC |
Zaremba Rabourn AmySVP of Finance
|
GrantCommon Stock | 39,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000941 · form4.xml · nonDerivative · entry 1 Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,968 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:05 UTC |
Jhaveri Nirav S.Chief Financial Officer
|
Tax withholdingCommon Stock | 8,207 | $1.15 | $9,438.05 |
DisclosureSEC source: 0000905148-25-000713 · form4.xml · nonDerivative · entry 1 Jhaveri Nirav S. · CIK 0002011481 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,793 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:04 UTC |
Jayagopal AshwathChief Scientific & Dev. Ofc.
|
Tax withholdingCommon Stock | 5,193 | $1.15 | $5,971.95 |
DisclosureSEC source: 0000905148-25-000712 · form4.xml · nonDerivative · entry 1 Jayagopal Ashwath · CIK 0002008983 · Chief Scientific & Dev. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,307 Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:37 UTC |
Zaremba Rabourn AmySVP of Finance
|
Tax withholdingCommon Stock | 8,190 | $1.14 | $9,336.60 |
DisclosureSEC source: 0000905148-25-000403 · form4.xml · nonDerivative · entry 1 Zaremba Rabourn Amy · CIK 0001832343 · SVP of Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,468 Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:35 UTC |
Hoffmann BernhardSVP of Corp. Dev.
|
Tax withholdingCommon Stock | 6,751 | $1.14 | $7,696.14 |
DisclosureSEC source: 0000905148-25-000401 · form4.xml · nonDerivative · entry 1 Hoffmann Bernhard · CIK 0001830354 · SVP of Corp. Dev. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,946 Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:42 UTC |
Bennett JeanDirector
|
GrantCommon Stock | 34,021 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-000038 · form4.xml · nonDerivative · entry 1 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,021 F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 16:43 UTC |
MANUSO JAMES S JDirector
|
GrantCommon Stock | 50,222 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-000039 · form4.xml · nonDerivative · entry 1 MANUSO JAMES S J · CIK 0001236365 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,259 F1 · price: The Reporting Person was granted shares of common stock in lieu of cash for board services for 2025. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock on the grant date (rounded down to the nearest whole share). The average fair market value was $1.23 per share, the average of the high and low price of the common stock on the date of grant. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 21:26 UTC |
Magrath GeorgeChief Executive Officer
|
PurchaseCommon Stock | 100,000 | $0.98 | $97,600.00 |
DisclosureSEC source: 0000905148-24-003425 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,150 F1 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.97 to $0.98, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 23, 2024 Filed Dec 23, 2024 22:50 UTC |
Magrath GeorgeChief Executive Officer
|
GrantCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-003406 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 499,150 F1 · kind: These shares were issued to the Reporting Person to correct an inadvertent over-withholding of shares on November 1, 2024, in connection with the vesting of restricted stock units on that date. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:18 UTC |
YERXA BENJAMIN RDirector · President
|
PurchaseCommon Stock | 10,000 | $0.98 | $9,834.00 |
DisclosureSEC source: 0000905148-24-003268 · form4.xml · nonDerivative · entry 1 YERXA BENJAMIN R · CIK 0001145910 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,800 Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:08 UTC |
Magrath GeorgeChief Executive Officer
|
PurchaseCommon Stock | 9,706 | $1.02 | $9,942.83 |
DisclosureSEC source: 0000905148-24-003236 · form4.xml · nonDerivative · entry 2 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 492,950 F2 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.005 to $1.06, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:08 UTC |
Magrath GeorgeChief Executive Officer
|
PurchaseCommon Stock | 90,294 | $1.01 | $91,215.00 |
DisclosureSEC source: 0000905148-24-003236 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,244 F1 · price: The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.975 to $1.05, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 21:35 UTC |
YERXA BENJAMIN RDirector · President
|
GrantCommon Stock | 332,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-003015 · form4.xml · nonDerivative · entry 1 YERXA BENJAMIN R · CIK 0001145910 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,800 F1 · shares: Represents a grant of restricted stock units which vest in four equal installments on the first, second, third, and fourth anniversary of October 22, 2024, subject to the Reporting Person's continuing service. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:13 UTC |
Magrath GeorgeChief Executive Officer
|
Tax withholdingCommon Stock | 37,050 | $1.18 | $43,719.00 |
DisclosureSEC source: 0000905148-24-002934 · form4.xml · nonDerivative · entry 1 Magrath George · CIK 0001999390 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,950 Read SEC document |
| October 22, 2024 Filed Oct 24, 2024 21:56 UTC |
Bennett JeanDirector
|
GrantStock Option (right to buy) · Derivative | 172,874 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0000905148-24-002827 · form4.xml · derivative · entry 2 Bennett Jean · CIK 0001872219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,874 Underlying: Common Stock · 172,874 shares Expires 2034-10-21 F2 · derivative.exercise_date: The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.